| 2014 | | An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease. | 김미애, 박해심 |
| 2017 | | Aspirin-exacerbated respiratory disease: an update | 박해심, 이지호 |
| 2015 | | Association of P2RY12 polymorphisms with eosinophil and platelet activation in patients with aspirin-exacerbated respiratory disease. | 김승현, 박해심 |
| 2014 | | Association of serum periostin with aspirin-exacerbated respiratory disease. | 남동호, 박해심, 반가영, 신유섭, 예영민, 유혜수 |
| 2019 | | Asthma pharmacotherapy: an update on leukotriene treatments | 박해심, 이소희 |
| 2014 | | Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis? | 김승현, 박해심, 예영민 |
| 2013 | | Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease. | 김미애, 박해심, 신유섭, 유혜수 |
| 2019 | | Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper | 박해심 |
| 2015 | | Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype. | 김승현, 박해심, 예영민 |
| 2012 | | Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease | 김승현, 박해심 |
| 2021 | | Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease | 박해심, 신유섭, 최영우 |
| 2013 | | Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. | 김승현, 박해심, 신유섭, 예영민 |
| 2014 | | Exonic variants associated with development of aspirin exacerbated respiratory diseases. | 박해심 |
| 2017 | | Genetic variants of the gasdermin B gene associated with the development of aspirin-exacerbated respiratory diseases | 박해심 |
| 2020 | | Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease | 박해심, 예영민 |
| 2023 | | Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort | 박래웅, 박해심, 이영수 |
| 2017 | | Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease | 김승현, 박해심, 반가영, 신유섭, 예영민 |
| 2017 | | Potential Biomarkers for NSAID-Exacerbated Respiratory Disease | 박해심, 정창규 |
| 2019 | | Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease | 김승현, 박해심, 신유섭 |
| 2014 | | The SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotype. | 김승현, 박해심, 예영민 |
| 2015 | | Upper airways in aspirin-exacerbated respiratory disease. | 김지혜, 박해심 |
